Health-care stakeholders increasingly recognize that the scientific and economic challenges associated with Alzheimer's disease (AD) are simply too great for individual stakeholder groups to address solely from within their own silos. In the necessary spirit of collaboration, we present in this perspective a set of multicountry multistakeholder recommendations to improve the organization of existing AD and dementia care and the development of new treatments. In brief, the five recommendations are (1) health-care systems must make choices regarding the patient populations to be diagnosed and treated, (2) health-care systems should use an evidence-based standard of care, (3) increased collaboration between public and private institutions is needed to enhance research, (4) reimbursement end points need to be agreed on and validated, and (5) innovative business models should be used to spur the introduction of new medicines.
Taking stock: A multistakeholder perspective on improving the delivery of care and the development of treatments for Alzheimer's disease / Bradley, P.; Akehurst, R.; Ballard, C.; Banerjee, S.; Blennow, K.; Bremner, J.; Broich, K.; Cummings, J.; Dening, K.; Dubois, B.; Klipper, W.; Leibman, C.; Mantua, V.; Molinuevo, J. L.; Morgan, S.; Muscolo, L. A. A.; Nicolas, F.; Pani, L.; Robinson, L.; Siviero, P.; Van Dam, J.; Van Emelen, J.; Wimo, A.; Wortmann, M.; Goh, L.. - In: ALZHEIMER'S & DEMENTIA. - ISSN 1552-5260. - 11:4(2015), pp. 455-461. [10.1016/j.jalz.2014.01.007]
Taking stock: A multistakeholder perspective on improving the delivery of care and the development of treatments for Alzheimer's disease
Pani L.;
2015
Abstract
Health-care stakeholders increasingly recognize that the scientific and economic challenges associated with Alzheimer's disease (AD) are simply too great for individual stakeholder groups to address solely from within their own silos. In the necessary spirit of collaboration, we present in this perspective a set of multicountry multistakeholder recommendations to improve the organization of existing AD and dementia care and the development of new treatments. In brief, the five recommendations are (1) health-care systems must make choices regarding the patient populations to be diagnosed and treated, (2) health-care systems should use an evidence-based standard of care, (3) increased collaboration between public and private institutions is needed to enhance research, (4) reimbursement end points need to be agreed on and validated, and (5) innovative business models should be used to spur the introduction of new medicines.File | Dimensione | Formato | |
---|---|---|---|
1-s2.0-S1552526014000338-main.pdf
Open access
Tipologia:
Versione pubblicata dall'editore
Dimensione
294.74 kB
Formato
Adobe PDF
|
294.74 kB | Adobe PDF | Visualizza/Apri |
Pubblicazioni consigliate
I metadati presenti in IRIS UNIMORE sono rilasciati con licenza Creative Commons CC0 1.0 Universal, mentre i file delle pubblicazioni sono rilasciati con licenza Attribuzione 4.0 Internazionale (CC BY 4.0), salvo diversa indicazione.
In caso di violazione di copyright, contattare Supporto Iris